Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

VIET H PHAM

Allopathic & Osteopathic Physicians Otolaryngology

NPI
1053570184
CMS profile
2211
Location
SAN ANTONIO, TX

General Payments · PY2018–2024

$1,279.49

  • Reported across 47 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$316.39

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $316.39 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GENZYME CORPORATION $138.24 7
Inspire Medical Systems, Inc. $77.01 2
Stryker Corporation $40.29 2
OptiNose US, Inc. $27.20 2
Hikma Pharmaceuticals USA $20.46 1
GlaxoSmithKline, LLC. $13.19 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $187.72 6
PY2019 $357.27 8
PY2021 $69.19 4
PY2022 $17.27 1
PY2023 $331.65 13
PY2024 $316.39 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20182019202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
GENZYME CORPORATION $16.93 01/18/2024 Food and Beverage Undisputed 01/23/2026 1140012976 CMS
GENZYME CORPORATION $15.85 04/10/2024 Food and Beverage Undisputed 01/23/2026 1140012990 CMS
GENZYME CORPORATION $19.42 04/24/2024 Food and Beverage Undisputed 01/23/2026 1140012996 CMS
GENZYME CORPORATION $27.79 06/19/2024 Food and Beverage Undisputed 01/23/2026 1140013010 CMS
GENZYME CORPORATION $20.33 07/29/2024 Food and Beverage Undisputed 01/23/2026 1140013016 CMS
GENZYME CORPORATION $19.91 08/21/2024 Food and Beverage Undisputed 01/23/2026 1140013026 CMS
GENZYME CORPORATION $18.01 10/18/2024 Food and Beverage Undisputed 01/23/2026 1140013038 CMS
GlaxoSmithKline, LLC. $13.19 10/07/2024 Food and Beverage Undisputed 01/23/2026 1116574974 CMS
Hikma Pharmaceuticals USA $20.46 11/22/2024 Food and Beverage Undisputed 01/23/2026 1127504047 CMS
Inspire Medical Systems, Inc. $23.08 02/07/2024 Food and Beverage Undisputed 01/23/2026 1148096108 CMS
Inspire Medical Systems, Inc. $53.93 09/03/2024 Food and Beverage Undisputed 01/23/2026 1148096110 CMS
Optinose US, Inc. $13.57 07/21/2024 Food and Beverage Undisputed 01/23/2026 1142186794 CMS
Optinose US, Inc. $13.63 10/14/2024 Food and Beverage Undisputed 01/23/2026 1142186808 CMS
Stryker Corporation $26.91 06/26/2024 Food and Beverage Undisputed 01/23/2026 1119945180 CMS
Stryker Corporation $13.38 08/13/2024 Food and Beverage Undisputed 01/23/2026 1119945182 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.